The Refill: Will Neuromodulation Use Increase?

CPA: Where do you believe the future of pain management is going?

GS: As the population ages and the baby boomer age retires, there will be more patients receiving treatment for acute and chronic pain. I think there will be more of a focus and other uses for neuromodulation will be developed in the next 10 years. Also, I believe that there will be new medications developed with a focus on chronic pain. 

CPA: How do you market your practice?

GS: We send letters to referring physicians and hold meetings with other physicians. We also participate in speaking engagements with large groups of potential patients, and via our website, web-based marketing, and research. Also providing safe, quality, comforting care often leads to word-of-mouth referrals.

CPA: What other revenue sources are you investigating in order to offset the drop in reimbursements?

GS: We’re trying to continue building practice partnerships with other offices.

CPA: How has your opioid prescribing habits changed?

GS: It has not changed much in the past few years. We now have the Internet System for Tracking Over-Prescribing (I-STOP) to check for controlled substances in New York. Any controlled substances that are filled at pharmacies show up on the I-STOP website. We also do urine screening in my practice to see if patients are taking the appropriate medications. We use pill counts. My practice is mostly interventional and has practiced safe opiate prescribing in the past and will continue to do so.

Interested in being featured in “The Refill”? Email CJ Arlotta at [email protected].